Sign in
4

Changes in Ownership

KALA BIO, Inc. Filed Acc 0000921895-25-003208

Options or other derivatives

  • Chief Executive Officer acquired 900,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lazar David E. · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-24 Grant or award : show line 1 in the form Series AA Convertible Preferred Stock +900,000 900,000 D
Loading xslF345X05/form412227001_11262025.xml…